Erythropoietin (Epo) is produced by renal Epo-producing cells (REPs) in a hypoxia-inducible manner. The conversion of REPs into myofibroblasts and coincident loss of Epo-producing ability are the major cause of renal fibrosis and anemia. However, the hypoxic response of these transformed myofibroblasts remains unclear. Here, we used complementary in vivo transgenic and live imaging approaches to better understand the importance of hypoxia signaling in Epo production. Live imaging of REPs in transgenic mice expressing green fluorescent protein from a modified Epo-gene locus revealed that healthy REPs tightly associated with endothelium by wrapping processes around capillaries. However, this association was hampered in states of renal injury-induced inflammation previously shown to correlate with the transition to myofibroblast-transformed renal Epo-producing cells (MF-REPs). Furthermore, activation of hypoxia-inducible factors (HIFs) by genetic inactivation of HIF-prolyl hydroxylases (PHD1, PHD2, and PHD3) selectively in Epo-producing cells reactivated Epo production in MF-REPs. Loss of PHD2 in REPs restored Epo-gene expression in injured kidneys but caused polycythemia. Notably, combined deletions of PHD1 and PHD3 prevented loss of Epo expression without provoking polycythemia. Mice with PHD-deficient REPs also showed resistance to LPS-induced Epo repression in kidneys, suggesting that augmented HIF signaling counterbalances inflammatory stimuli in regulation of Epo production. Thus, augmentation of HIF signaling may be an attractive therapeutic strategy for treating renal anemia by reactivating Epo synthesis in MF-REPs.
disease, including kidney diseases. 34, 35 In that regard, a clinical trial has successfully reported that pharmacological activation of HIF signaling can augment Epo-production in ESRD. 36 However, the hypoxic response of REPs during disease is largely unstudied, and the mechanisms underlying the re-establishment of Epo synthesis in fibrotic kidneys are unclear. We hypothesized that the HIF-mediated hypoxic response might be insufficient or deteriorated in MF-REPs in injured kidneys and that augmenting their hypoxic response might reactivate their physiologic function.
In this study, we conducted in vivo transgenic and live imaging approaches to better understand the importance of hypoxia signaling in injured kidneys. We analyzed the adequacy of . Under a two-photon microscope, REPs and peritubular capillaries were detected with GFP expression (green) and rhodamine B-conjugated 70-kD dextran (red), respectively (B and C; high magnification views of A). Note that many processes from the cell body of REPs were attached along with the capillary walls at baseline (B and C), whereas some of the processes detached from the capillary wall (arrows in D) and attached to the tubular wall (arrowheads in E and F). Tubules (T) were visualized by the auto-fluorescence from the urine. (G) Quantification of the process directions of REPs. Numbers of directions either toward capillaries or toward tubules were counted. The data (mean6SD, n=3) indicate that the direction of the primary process of REPs changes toward the tubular side upon 3 days of UO. The number of process was not changed by the UUO procedure (normal REPs: 4.860.2 versus UUO-treated REPs: 5.360.4).
hypoxia signaling, dynamic morphologic changes of myofibroblast transformation of REPs, and the isoform-specific functions of PHDs and HIFs in REPs under health and disease conditions. Through these analyses, we discovered that the augmentation of HIF signaling in MF-REPs reactivates the Epo synthesis without worsening of fibrosis or inflammation. Our results indicate that HIF signaling activators are attractive therapeutic reagents for restoring the Epo-producing ability of REPs and treating cardio-renal anemia syndrome.
RESULTS

Morphologic Changes of REPs by Kidney Injury
To examine phenotypic changes of REPs in damaged kidneys, we performed live imaging of REPs using inherited super anemic mice (ISAM), in which the REPs express bright green fluorescence from the modified Epo-gene locus. 14, 17 REPs retain a number of processes in healthy kidneys, and their processes form networks surrounding capillaries ( Figure 1A ). Highmagnification images further demonstrate that the processes are tightly interconnected and are wrapping the capillaries (Figure 1 , B and C). This observation suggests that REPs and renal pericytes may be largely overlapping cellular populations. 37 Upon unilateral ureteral obstruction (UUO) for 3 days, a model for inducing fibrogenic milieu, 17 the processes of REPs started to detach from their associated capillaries in the ureteral-obstructed kidneys (UO-kidneys; Figure 1D ). Instead, the processes started to associate with the adjacent tubules ( Figure 1 , E and F); approximately 60% of the processes were associated with the capillaries in normal kidneys, but more than 80% of the processes were associated with or in juxtaposition of tubules in UOkidneys ( Figure 1G ). These results indicate that the deterioration of renal milieu alters the morphology of REPs and the direction of their processes, concomitant with the transformation of REPs into myofibroblast.
Exacerbated Hypoxia in Injured Kidneys
It has been suggested that kidney injuries and subsequent fibrosis disrupt the oxygen delivery through vascular rarefactions and the excessive accumulation of extracellular matrix. [2] [3] [4] Tissue hypoxia was assessed by the accumulation of pimonidazole, which forms adducts in hypoxic cells with PO 2 ,10 mmHg. 4 UO-kidneys at Figure 2 . Kidney injury augments the hypoxic milieu. (A) Pimonidazole immunoblotting of whole kidney lysates. Pimonidazole-conjugated proteins were more abundantly accumulated in the injured kidneys by ureteral obstruction (UO) for 2 days than in the contralateral (Cont) or normal kidneys. a-Tubulin was used as a loading control. (B) Surface oxygen tension of UO-kidneys. Note that kidney surface oxygen tensions were reduced rapidly by UO. Green color indicates higher oxygen concentration than orange. (C) Pimonidazole immunoblotting of whole kidney lysates from ISAM (Epo GFP/GFP ::Tg Epo39 ) and control littermates (Epo GFP/wt ::Tg Epo39 ). Pimonidazole-conjugated proteins were accumulated in the kidney of ISAM due to the anemia, and the accumulation was enhanced by UO for 2 days compared with the contralateral kidneys (Cont). Labels #1 and #2 indicate different samples. a-Tubulin was used as a loading control. (D) Pimonidazole immunostaining of kidney sections. Hypoxic areas (brown, positive for pimonidazole adducts) of the ISAM kidney were widely spread throughout the cortical area after UO for 2 days (UO-kidney, right panels). Scale bar, 200 mm. (E) Mitochondrial membrane potential in injured kidneys of ISAM. TMRM, an indicator of mitochondrial membrane potential, was injected at each time indicated in the panels, and the fluorescent intensity (pseudo color) was measured by two-photon microscopy. The TMRM fluorescence in the tubular epithelial cells was high (orange to white) before obstruction (Pre), and the signals were decreased (dark blue to black) 4 hours after obstruction. Scale bar, 50 mm. day 2 of UUO exhibited marked accumulation of pimonidazoleadducted proteins compared with the contralateral kidneys and normal uninjured kidneys ( Figure 2A ). Oxygen supply to the UO-kidneys was also measured by using an oxygen-sensor foil VisiSens system, 38 showing that the oxygen tension on the kidney surface was significantly decreased at 30 minutes after UUO ( Figure 2B ).
We then investigated the effects of injury in the setting of chronic hypoxia/anemia by utilizing ISAM, as a model of chronic anemia. 14, 17 ISAM kidneys showed marked accumulation of pimonidazole-conjugated proteins compared with the control littermate kidneys ( Figure 2C ). In ISAM kidneys, cortical pimonidazole immunoreactivity was observed, indicating that the hypoxic area was widespread in the ISAM kidneys ( Figure 2D ), in contrast to the selective medullary hypoxia observed in control littermate kidneys. 14, 17 The pimonidazole immunoreactivity was enhanced by ureteral obstruction-induced injury ( Figure 2 , C and D), indicating deterioration of the hypoxic milieu in the UOkidneys.
To determine the functional consequence of injury superimposed on anemia, we utilized in vivo live imaging and measured mitochondrial membrane potentials using tetramethylrhodamine methyl ester (TMRM) in ISAM kidneys. TMRM was rapidly distributed in the mitochondria of tubular cells (Supplemental Figure 1 ) and showed bright fluorescence ( Figure 2E ). The fluorescent intensity of TMRM was markedly decreased at 4 hours after UUO. These results indicate that mitochondrial activity of UO-kidneys was severely damaged, confirming the notion that oxygen availability in injured kidneys is compromised. 2, 4, 34, 39 Disrupted Hypoxic Response in Injured Kidneys In order to examine the hypoxia response of the injured kidneys superimposed on anemia, we then explored the HIF-mediated hypoxia response using ISAM kidneys with UUO. While control ISAM kidneys showed a robust accumulation of HIF1a proteins compared with the kidneys of the control littermates, the level of HIF1a accumulation was reduced in the injured kidneys at 2 days after UUO despite the worsening hypoxia ( Figure  3A ). This result suggests that the kidney injuries disturb the hypoxia-responsive pathway.
To explore the consequences of defects in the hypoxia-responsive HIF accumulation, the mRNA levels of HIF target genes, which were identified based on the literature, 25, 27, 40, 41 were examined using our previous microarray data from injured and normal ISAM kidneys. 17 Of the 67 HIF target genes identified a priori, 21 were upregulated more than 1.5-fold by ureteral obstruction for 2 days, whereas 28 were downregulated more than 1.5fold ( Figure 3B ). The remaining 18 genes were unchanged. Similar to the case of the Epo-GFP gene, the indicator of the endogenous Epo-gene activity, 17 the HIF target genes, such as Aldoc, Pdk1, Car9, and Vegfa, were continuously repressed by the ureteral obstruction-induced injury throughout the 2-week experimental period ( Figure 3C , Supplemental Figure  2 ). These results demonstrate that HIF signaling in the kidneys is deteriorated upon injuries and becomes insufficient to support the hypoxic response.
Selective Deletion of PHD Isoforms in REPs Causes Polycythemia
We further investigated the functional roles of the hypoxiaresponsive pathway in REPs by using genetically modified mouse lines. We deleted genes for PHDs and/or HIF2a selectively in Epo-producing cells by using the Epo-Cre transgene (herein referred to as Epo-Cre-mediated knockout (EKO) mice). 14, 17 The Epo-Cre mice were crossbred with mice bearing conditional knockout alleles of Egln1, Egln2, Egln3, and Epas1 (encoding PHD2, PHD1, PHD3, and HIF2a; Supplemental Figure 3 ). A single knockout of Egln1 (P2-EKO) or the combined deletion of Egln1 and other genes for PHDs in Epo-producing cells (P12-EKO, P23-EKO, and P123-EKO) resulted in polycythemia ( Figure 4A ). In contrast, combined deletion of PHD1 and PHD3 (P13-EKO) did not give rise to polycythemia.
The increased hematocrit level (Hct) and size of spleens in the PHD-deficient mice ( Figure 4B ) were completely counteracted by the concomitant deletion of the Epas1 gene (P123H2-EKO in Figure 4 , A and C), demonstrating the functional dependence on HIF2a in these phenotypes. Surprisingly, the plasma Epo levels in P123-EKO mice were not significantly different from the control littermates ( Figure 4D ), suggesting that the sustained unregulated secretion of Epo, which was not repressed by the increased Hct, is responsible for the observed polycythemia ( Figure 4 , A-D).
There are two major Epo-producing organs, kidney and liver. Additionally, brain also produces Epo to some extent. [13] [14] [15] 28 Of these organs, kidney was the major source of Epo in the P123-EKO model ( Figure 4E ). Whereas it has been reported that Epo synthesis was activated in hepatocytes 23, 42, 43 and glial cells 44 by the deletion of PHDs or pVHL, we did not observe a marked elevation of Epo synthesis in the liver and brain of P123-EKO mice. This observation may be explained by the low efficiency of the PHD deletions in these cells, as the expression levels of the Epo-Cre transgene were lower in these cells than in REPs (Supplemental Figure 4 ).
Epo-gene Expression in Injured Kidneys Is Restored by The Loss of PHDs
To define the role of each PHD upon kidney injury in vivo, we applied UUO to PHD-EKO mice. In control littermates, the ureteral obstruction-induced injury repressed Epo mRNA expression to less than 10% of the contralateral uninjured kidneys at 2 days after UUO ( Figure 5A ). Notably, the UO-kidneys with deletion of the Egln1 gene alone (P2-EKO) and in combination with Egln2 and/ or Egln3 (P12-EKO, P23-EKO, and P123-EKO) showed higher Epo mRNA levels than the UO-kidneys of control mice, indicating that PHD2-deficiency protected Epo production in damaged REPs. The UO-kidneys of P123-EKO mice showed the highest Epo mRNA levels ( Figure 5A ), but the protective effects of PHD deletions were not additive, suggesting that each PHD might perform redundant functions in diseased REPs. Importantly, the combined deficiency of PHD1 and PHD3 in REPs, which did not provoke polycythemia, showed a similar level of resistance to Epo repression compared with P2-EKO mice ( Figure 5A ).
Next, we examined the effect of PHD deficiency on later stages of kidney injury. The Epo-gene expression in the UO-kidneys in the control mice was reduced to almost 20% of the contralateral kidneys at 7 and 14 days after UUO ( Figure 5B) . Surprisingly, the Epo mRNA levels in the UO-kidneys of P123-EKO mice were 2-and 4-fold higher than in the contralateral kidneys at 7 and 14 days after UUO, respectively ( Figure 5B ). This overactive Epo synthesis in fibrotic kidneys might be due to the proliferation of myofibroblast-transformed REPs with preserved Epo-producing potentials and the enrichment of these cells by the reduction of tubular cells (Supplemental Figure 5 ). 17 We previously reported that LPS treatment suppresses renal Epo mRNA expressions through activation of inflammatory signaling. 17 Whereas the Epo-gene expression was reduced to 14% at 6 hours after LPS injection in the control genotype mice, the Epo-gene expression in P123-EKO mice was only reduced to 46%, protected from the LPS-mediated suppression ( Figure 5C ).
The PHD-deficient MF-REPs Synthesize Epo
To validate the notion that the PHD-deficient MF-REPs synthesize Epo, we generated Epo GFP/wt P123-EKO mice by crossbreeding P123-EKO mice with Epo GFP/wt mice. In control Epo GFP/wt mice (Cre -; Figure 6A ), UUO for 14 days destructed renal structure and completely abolished GFP expression. However, GFP + cells were observed in the UO-kidneys of Epo GFP/wt P123-EKO mice (Cre + ; Figure 6, A and B) .
Interestingly, the GFP + cells expressed a-smooth muscle actin (aSMA), a myofibroblast marker, in different expression levels in UO-kidneys of Epo GFP/wt P123-EKO mice ( Figure 6C ). This observation indicates that the Epo synthesis is maintained in both fully myofibroblast-transformed and myofibroblasttransitioning REPs with PHD deficiency. These data clearly demonstrate that the Epo-gene expression is restored by PHD deficiency in MF-REPs.
REP-specific Deletion of PHDs Does Not Affect Progression of Renal Fibrosis
To determine the effects of REP-specific deficiency of PHDs on renal fibrosis, we evaluated the collagen accumulation in injured kidneys. Picrosirius-red staining showed a similar level of accumulated collagens in the kidneys of P123-EKO mice to the levels in the controls upon UUO for 14 days (Figure 7, A and B) . The mRNA expression levels of genes for collagen (Col1a1 and Col3a1), aSMA (encoded by Acta2), and fibrogenic and inflammatory cytokines (Tgfb1, Tnfa, and Il6) were not affected by the PHD deficiency on day 7 and day 14 of UUO ( Figure 7C ). Furthermore, the expression levels of cellular markers for infiltrating leukocytes (F4/80, CD45, and CD11b) were also in similar levels ( Figure 7C ). These results indicate that the activation of hypoxia signal selectively in REPs restores the Epo-gene expression, but does not affect pathologic fibrogenic and inflammatory responses.
DISCUSSION
REPs are the major Epo-producing cells in adults, maintaining tissue oxygen homeostasis by supporting erythropoiesis. In disease, REPs become the major source of myofibroblasts, contributing to a final common pathway of CKD, i.e., renal fibrosis. 17 Although REPs lose their Epo-producing ability by myofibroblastic transformation, injured REPs recover their original features, including Epo production, after resolution of the fibrogenic inflammatory stimuli. 17 These findings led us to hypothesize that the signals evoked in fibrogenic milieu inhibit transcriptional activation of the Epo gene in MF-REPs. Here we demonstrate that the regulatory system for the hypoxia-inducible genes is impaired in injured kidneys despite their severe hypoxic milieu, leading to insufficient HIF-mediated cellular responses. Deletion of the PHD isoforms in REPs results in the reactivation of the Epo-gene expression in MF-REPs. Moreover, the analyses of compound conditional knockout mice show that the PHD2-HIF2a axis is the major regulatory cascade for hypoxia-inducible Epo-gene expression in REPs, in both health and disease.
We have analyzed the physiologic role of PHD isoforms in REPs using REP-specific PHD knockout mice. Consistent with the systemic knockout studies, 29, 31 the single and combinatorial PHD2 deletion leads to uncontrolled Epo-gene expression and results in polycythemia, which is abolished by HIF2a deficiency. This observation indicates that HIF2a, but not HIF1a, is the major transcriptional activator of the Epo gene in REPs and that PHD2, rather than the other PHD isoforms, mainly catalyzes oxygen-dependent hydroxylation of HIF2a proteins. Indeed, the expression level of HIF2a is higher in REPs than the other kidney cells, whereas HIF1a is expressed primarily in tubular cells. 15, 45 This specific PHD usage for the Epo-gene regulation in REPs is unique compared with the situation in hepatocytes in which PHD1 and PHD3 are as important as PHD2, thereby requiring the deletion of all PHDs to induce uncontrolled HIF2a-mediated polycythemia. [29] [30] [31] 46 Epo-deficiency anemia is a most frequently observed complication of CKD. We have shown that the loss of the Epo-producing ability of MF-REPs is a critical component of its pathogenesis. 17, 18 However, the roles of PHDs and HIFs for the regulation of Epo gene in MF-REPs have been poorly understood. Through the analyses of conditional PHD knockout mice lines, we show that that the loss of PHDs in REPs reactivates Epo-gene expression in MF-REPs, suggesting that inflammatory and/or fibrogenic signals suppress HIFs through the overactivation of PHDs even under pathologic hypoxic conditions ( Figure 8A) .
To test this hypothesis, we have assessed the renal Epo-gene expression of P123-EKO mice under LPS-induced inflammation. The PHD deletion in REPs attenuates the LPS-induced Epo-gene suppression, indicating that inflammatory signaling accelerates PHD-mediated HIF degradation. Although the mechanism underlying how PHDs inactivate HIFs in hypoxic MF-REPs needs future studies, we propose that Epo expression in MF-REPs is regulated by the activity of PHDs in the balance of hypoxia-induced inhibition and inflammation-induced activation. Tipping the balance toward HIF activation through inactivation of PHDs in MF-REPs is important for maintaining or reactivating Epo synthesis in diseased kidneys.
Strategies to treat kidney diseases by augmenting HIF signaling have been rigorously studied using both genetic and pharmacological tools. The activation of HIF signaling in different kidney cell types produces different consequences for renal inflammation and fibrosis. 3 The deletion of the gene for pVHL in podocytes 47 and proximal tubular cells 48 result in worsening kidney disease, whereas deletions in myeloid cells, endothelial cells, and the whole body improve renal inflammation and fibrosis. 49, 50 Our results show that HIF activation in anemic injured kidneys is insufficient, thereby augmenting HIF signaling is an attractive therapeutic strategy. However, overactivation of HIFs has been raised a concern regarding undesired complications. 31, 35, 51 Therefore, identifying the most appropriate way to re-activate HIF-signaling is urgently needed.
To this end, we compared the effects of the loss of each PHD isoform in REPs in diseased and healthy kidneys, and found that mice with a combined deficiency of PHD1 and PHD3 in REPs exhibited resistance to Epo repression in the event of renal injury, but did not exhibit polycythemia. We propose that inhibitors that selectively target PHD1 and PHD3 are attractive for further drug development, as they would minimize the complications of overactive HIF signaling ( Figure 8B ). Indeed, PHD1 and PHD3 have been in the spotlight as target molecules for protecting other organs (e.g., liver 52 and muscle, 53 and so on) without polycythemic effects, which supports our findings.
In summary, we show that attenuated HIF signaling in myofibroblast-transformed REPs is a major cause of renal anemia. Augmentation of HIF signaling by inhibiting PHDs is an attractive therapeutic strategy for renal anemia and for halting the vicious cycle of cardio-renal anemia syndrome by re-activating Epo synthesis from damaged and transformed REPs.
CONCISE METHODS
Mice
Mice were maintained in a specific pathogenfree facility. All experimental procedures have been approved by the Animal Care Committee at Tohoku University. Mice bearing Epo-producing cell-specific knockout alleles of genes for PHDs and HIF2a were generated by breeding Epo-Cre (Tg Epo-Cre ) mice (see Supplemental Figure 6 explaining the expression profile of the Epo-Cre transgene) 14, 17 with conditional knockout mice of Egln1, Egln2, Egln3, and Epas1 genes (encoding PHD2, PHD1, PHD3, and HIF2a, respectively; see Supplemental Figure 3 ). 29, 46 Epo GFP/wt mice and ISAM (Epo GFP/GFP ::Tg Epo39 genotype) established in house were also used. 14, 17 Rosa26R-STOP-tdTomato (R26T ) mice and Alb-Cre transgenic mice were obtained from The Jackson Laboratory (Stock no. 007980 and 003574, respectively; Bar Harbor, ME). 54, 55 The mouse genotypes were determined by PCR of tail DNA with the primers listed in Supplemental  Table 1 . Littermate mice with a mixed genetic background were used for comparisons in the analyses.
Surface Tissue PO 2 Measurement
Mice were anesthetized with pentobarbital, and the left kidney was exposed. Then, the kidney was covered by the oxygen sensor foil (PreSens GmbH, Regensburg, Germany), and the surface oxygen tension was measured by a Visisens A1 detector camera with imaging software (PreSens GmbH).
Pimonidazole Treatment
To detect hypoxic areas, mice were intraperitonealy injected with 60-mg/kg pimonidazole (Hypoxyprobe Inc., Burlington, MA) and sacrificed 1 hour after the injection. Kidneys were used for immunoblotting and immunohistochemistry. The rabbit polyclonal antibody (for immunoblotting) and the FITC-conjugated mouse monoclonal antibody (for immunohistochemistry) were used.
UUO Model
UUO model was generated as we previously described. 17 The left ureter was exposed by a flank incision and ligated. To evaluate the Epo-producing potential, the Epo mRNA expressions were quantified in comparison with those of the contralateral (Cont) kidney, which was used to normalize individual differences of Hct levels. Sham operation was performed in the same way except for ligating the ureter.
LPS Treatment
Mice were intraperitonealy injected with 0.1-mg/g body wt LPS (Sigma-Aldrich, St. Louis, MO). 17 At six hours after single injection, mice were sacrificed and their kidneys were harvested for RNA isolation. The vehicle-treatment group was used as controls.
Western Blotting
Whole kidney lysates were prepared and transferred to PVDF (polyvinylidene fluoride) membranes after SDS-PAGE. The membranes were immunoblotted with antibodies against HIF1a (Abnova, Taipei, Taiwan), HIF2a (LSBio, Seattle, WA), pimonidazole (Hypoxyprobe, Inc.), a-Tubulin (Sigma-Aldrich, St. Louis, MO), and b-Tubulin (Sigma-Aldrich). To detect signals, horseradish peroxidase-conjugated secondary antibody against rabbit (Dako, Glostrup, Denmark) or goat immunoglobulins (Santa Cruz Biotechnology, Dallas, TX) were used with chemiluminescence staining reagents (GE Healthcare, Little Chalfont, UK).
Real-time PCR Analysis
Isogen (Nippongene, Tokyo, Japan) was used to prepare total RNA. Total RNA (3 mg) was used for reverse transcription using random hexamers and Superscript III polymerase kit (Invitrogen, Waltham, MA). Real-time PCR was then performed with the primers listed in Supplemental Table 1 . Gene expression levels were calculated based on the threshold cycle (Ct) values and the efficiency of each primer set, and expressed as relative to 18S rRNA.
Tissue Preparation for Histologic Analysis
To prepare frozen sections, tissues were fixed with 4% paraformaldehyde for 2 hours, washed with 20% sucrose in PBS overnight, and then embedded in OCT compound (Sakura FineTek, Tokyo, Japan). Tissues for paraffin-embedded sections were fixed with 4% paraformaldehyde for 48 hours. Interstitial fibrosis was evaluated by Picrosirius-red staining (Polysciences, Warrington, PA), and the collagen-positive areas were quantified using ImageJ software. Immunohistochemistry 10-mm frozen sections or 3-mm paraffin sections were used. Paraffinembedded samples were antigen unmasked by target retrieval solution (Dako; pH 6.0). Sections were blocked and incubated with primary antibodies against FITC-conjugated aSMA (Sigma-Aldrich) or pimonidazole (Hypoxisense, Hypoxyprobe-1 plus kit; Hypoxyprobe, Inc.). Nuclei were stained by 4' ,6-diamidino-2-phenylindole for fluorescent detection. Fluorescent images were obtained using an LSM510 confocal imaging system (Carl Zeiss, Jena, Germany). For pimonidazole staining, signals were obtained using diaminobenzidine solution (DAB, Dako), and sections were counter stained by hematoxylin. In REPs sensing hypoxia (ON-REP), oxygen-dependent PHD activity is blocked; thereby HIF2a is stabilized for activation of the Epogene transcription. Kidney injuries induce myofibroblastic transformation of REPs through the activation of inflammatory and fibrogenic signals 17 and inactivate HIF2a through PHDs in spite of their worsened hypoxic milieus. Therefore, the inactivation of PHDs in MF-REPs leads to reactivation of Epo-gene expression. (B) Summary of the results from deletion of genes for PHD isoforms in REPs. This study proposes a therapeutic window (blue, around double deletion of PHD1 and PHD3) for inducing Epo production from diseased kidneys without polycythemic complications caused by PHD2 deletion.
Live Imaging Using Two-Photon Microscopy
Real-time live imaging of ISAM kidneys was performed through twophoton microscopy using a Leica TCS SP5 multiphoton confocal fluorescence imaging system. 56 Briefly, mice were anesthetized with ketamine and xylazine, and the left kidneys were exteriorized and placed on the microscope stage. TMRM (5 mg/kg) and rhodamine B-conjugated 70-kD dextran (for visualizing blood flow) were injected through the jugular vein, and the signal was measured immediately after the each dye injection (0, 1, and 4 hours after UUO; see Supplemental Figure 1 ). The direction of major processes of more than five REPs were counted in each three-dimensional field.
Statistical Analyses
Data were expressed as mean6SD. Comparisons between groups were performed using one-way ANOVA or an unpaired Student's t test as appropriate. For multiple comparisons, the Tukey-Kramer test was used. Data were considered statistically significant at P,0.05.
